All In Biotech

Drug Trial Radar · NCT03794557

The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD

A Phase 2, Single-Center, Double-Blind, Placebo-Controlled, Study of PUL-042 Inhalation Solution in Rhinovirus-induced Symptoms in Current Smokers With Gold Stage 0 Chronic Obstructive Pulmonary Disease (COPD)

Last checked: Nov 19, 2026Latest source record: Jun 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Jan 21, 2019

Primary completion

Dec 16, 2020

Study completion Mar 23, 2021

Sponsor

Lead sponsor
Pulmotect, Inc.Industry
Sponsor type
Industry
Collaborators
Imperial College Healthcare NHS Trust; VirTus Respiratory Research Ltd; MWB Consulting Ltd; Data Magik Ltd
First posted
Jan 7, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study examining the effect of inhaled PUL-042 on peak lower respiratory symptoms as measured by subject diary in early stage COPD subjects who are experimentally infected with rhinovirus. Subjects will receive 1 dose of PUL-042 followed by inoculation with HRV A16 virus 24 hours later. An additional dose of PUL-042 will be administered 48 hours post-inoculation. Subjects will be followed for 6 weeks post-inoculation

Conditions

  • COPD

Interventions

  • Sterile Water InjectionDrug

    Inhaled Sterile Water Injection

  • PUL-042 Inhalation SolutionDrug

    PUL-042 Inhalation Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lower Respiratory Symptom Score as measured by Mallia et al (Am J Respir Crit Care Med. 2011)Time frame: Daily Scores Day 0-42

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Imperial College Healthcare NHS Trust, St Mary Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.